Press release
Amniotic Membrane Market to Grow at a CAGR of 7.33% Through 2032, Driven by Rising Applications in Ophthalmology and Regenerative Medicine | DelveInsight
Amniotic Membrane Market
DelveInsight's Amniotic Membrane - Market Insights, Competitive Landscape, and Market Forecast - 2032 report delivers a detailed analysis of market dynamics, competitive developments, and market share insights, along with profiles of leading companies. The study highlights key growth drivers, challenges, and emerging opportunities shaping the future of the global amniotic membrane market.
Explore the latest trends and growth drivers in the download your sample report on the amniotic membrane market now https://www.delveinsight.com/report-store/amniotic-membrane-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the Amniotic Membrane Market Report
• The global amniotic membrane market is projected to experience significant growth, expanding at a CAGR of 7.33%, and reaching a substantial value by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global amniotic membrane market during the forecast period.
• Notable amniotic membrane companies such as BioTissue, Inc., Corza Ophthalmology, Integra LifeSciences, Merakris Therapeutics, Inc., Seed Biotech, Inc., Atlas Ocular, BioLab Holdings, Inc., Orthofix Medical Inc., Labtician Ophthalmics Inc., Smith & Nephew, Organogenesis Inc., Celularity Inc., Tides Medical, StimLabs, MIMEDX Group, Inc., NuVision Biotherapies Ltd., Next Biosciences, Sanara MedTech Inc., Axogen Corporation, Dynamic Medical Services DBA Acesso Biologics, and several others are currently operating in the amniotic membrane market.
• In April 2025, BioTissue Inc. announced that the new research will be presented at the 2025 American Urological Association Conference in Las Vegas which evaluated robotic ureteral reconstruction using Clarix® 1K, an ultra-thick cryopreserved amniotic membrane by BioTissue Surgical. In a study of 17 patients, 88% showed symptomatic improvement and 76% had radiographic improvement at one-year follow-up. Researchers concluded that Clarix® 1K was a safe and effective alternative to autologous grafts for medium-length ureteral strictures.
• In November 2024, Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.
• In October 2024, Merakris Therapeutics launched Dermacyte AC Matrix, a lyophilized amniotic-chorion membrane allograft, at the Fall Symposium for Advanced Wound Care in Las Vegas. The product featured multiple membrane layers and an optimized bioprocess, offering better protein retention and maintaining key physical and biological properties of placental membranes.
To read more about the latest highlights related to the amniotic membrane market, get a snapshot of the key highlights entailed in the global amniotic membrane market report here https://www.delveinsight.com/report-store/amniotic-membrane-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Amniotic Membrane Overview
The amniotic membrane is the innermost layer of the placenta, composed of a thin, tough, and transparent tissue that surrounds and protects the fetus during pregnancy. It is rich in collagen, growth factors, and anti-inflammatory proteins, which contribute to its unique regenerative and healing properties. Due to these characteristics, amniotic membranes have been widely used in medical applications, particularly in ophthalmology for treating corneal injuries, burns, and chronic wounds, as well as in surgical grafts to promote tissue repair and reduce inflammation.
In recent years, advances in processing and preservation techniques have expanded the use of amniotic membranes in various fields, including regenerative medicine and orthopedics. Their ability to modulate inflammation, reduce scarring, and promote cell growth makes them valuable for treating soft tissue injuries and chronic conditions. Amniotic membrane products are available in different forms such as cryopreserved, dehydrated, or lyophilized, allowing tailored applications depending on clinical needs.
Amniotic Membrane Market Insights
North America is expected to lead the amniotic membrane market in 2024, driven by the rising prevalence of chronic wounds like diabetic foot ulcers, ophthalmic disorders such as neurotrophic keratopathy and dry eye disease, and strong healthcare infrastructure. Amniotic membranes, rich in growth factors and anti-inflammatory components, effectively support healing and tissue regeneration in these conditions. Market growth is further boosted by innovations from key players, including Celularity's BIOVANCE® products for ocular surface treatment. These factors collectively are set to fuel significant market expansion through 2032.
To know more about why North America is leading the market growth in the amniotic membrane market, get a snapshot of the amniotic membrane market outlook here https://www.delveinsight.com/report-store/amniotic-membrane-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Amniotic Membrane Market Dynamics
Globally, the amniotic membrane market is growing due to the high incidence of road traffic injuries causing complex wounds, and the increasing prevalence of diabetes and diabetic foot ulcers, which affect millions annually. Amniotic membranes promote faster healing, reduce inflammation, and lower infection risks in these conditions. Additionally, the rising number of ophthalmic disorders like dry eye disease and neurotrophic keratitis drives demand, as amniotic membranes offer advanced regenerative benefits over traditional treatments. Innovations such as Axogen's Avive+ Soft Tissue MatrixTM further support market growth. However, challenges like competition from alternative products and the limited shelf life of cryopreserved membranes may restrict expansion.
Get a sneak peek at the amniotic membrane market dynamics @ https://www.delveinsight.com/report-store/amniotic-membrane-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
Amniotic Membrane Market CAGR: ~7.33%
Key Amniotic Membrane Companies: BioTissue, Inc., Corza Ophthalmology, Integra LifeSciences, Merakris Therapeutics, Inc., Seed Biotech, Inc., Atlas Ocular, BioLab Holdings, Inc., Orthofix Medical Inc., Labtician Ophthalmics Inc., Smith & Nephew, Organogenesis Inc., Celularity Inc., Tides Medical, StimLabs, MIMEDX Group, Inc., NuVision Biotherapies Ltd., Next Biosciences, Sanara MedTech Inc., Axogen Corporation, Dynamic Medical Services DBA Acesso Biologics, and others.
Amniotic Membrane Market Segmentation
Market Segmentation By Type: Dehydrated Amniotic Membranes and Cryopreserved Amniotic Membranes.
Market Segmentation By Application: Surgical Wounds, Ophthalmic Disorders, and others.
Market Segmentation By End User: Hospitals, Ambulatory Surgical Centres, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the amniotic membrane market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/amniotic-membrane-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Amniotic Membrane Market Report Introduction
2. Amniotic Membrane Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Amniotic Membrane Market Key Factors Analysis
6. Amniotic Membrane Market Porter's Five Forces Analysis
7. Amniotic Membrane Market Layout
8. Amniotic Membrane Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us
Jatin Vimal
jvimal@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Amniotic Membrane Market to Grow at a CAGR of 7.33% Through 2032, Driven by Rising Applications in Ophthalmology and Regenerative Medicine | DelveInsight here
News-ID: 4160392 • Views: …
More Releases from DelveInsight
PH-ILD Market Size in the 7MM was ~USD 3 Billion in 2024 and is projected to inc …
DelveInsight's "Pulmonary Hypertension associated with Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of PH-ILD, historical and forecasted epidemiology, as well as the PH-ILD market trends in the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
Discover Key Insights into the Pulmonary Hypertension associated with Interstitial Lung Disease Market with DelveInsight's In-Depth Report @ Pulmonary Hypertension associated with…
Sensorineural Hearing Loss Clinical Trials Analysis 2025: Emerging Regenerative …
DelveInsight's "Sensorineural Hearing Loss Clinical Trials Analysis, 2025" describes a rapidly evolving pipeline targeting both restoration of inner-ear structures and symptomatic improvement. Ongoing programs span hair cell regeneration via small molecules and biologics, AAV- and non-viral gene-replacement or gene-editing strategies for monogenic deafness, cell-based therapies (supporting synaptic reconnection), and cochlear neuromodulation advancements to augment residual hearing. Trials increasingly pair novel delivery methods (e.g., intracochlear, round-window) with precision patient selection based…
Cell and Gene Therapy in Parkinson's Disease Clinical Trials Analysis 2025: Dise …
DelveInsight's "Cell and Gene Therapy in Parkinson's Disease - Clinical Trials Analysis, 2025" highlights a diversified development landscape pursuing symptomatic relief and disease modification. Programs include dopamine-restorative cell implants, neuroprotective gene therapies targeting α-synuclein aggregation or neuroinflammation, and circuit-targeted gene delivery to rebalance basal ganglia networks. Trials incorporate advanced delivery (stereotactic infusion), standardized imaging and molecular biomarkers, and combination strategies pairing cell/gene therapy with neuromodulation.
Pivotal and late-phase trials focus on…
Staphylococcal Infections Clinical Trials Analysis 2025: New Antibacterials, Ant …
DelveInsight's "Staphylococcal Infections Clinical Trials Analysis, 2025" outlines a focused effort to tackle antibiotic resistance and severe invasive disease. Active programs include novel small-molecule antibacterials with activity against MRSA, anti-virulence and quorum-sensing inhibitors, monoclonal antibodies targeting toxins and surface proteins, and host-directed immunotherapies to enhance clearance. Trials cover a range of indications from complicated skin and soft tissue infections to bacteremia and prosthetic-joint infections, with increasing attention on combination regimens…
More Releases for Amniotic
Surge In Transplants Drives Growth In The Amniotic Membrane Market: Transformati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Amniotic Membrane Industry Market Size Be by 2025?
Notable growth has been observed in the amniotic membrane market size in previous years. The market, which is projected to escalate from $1.75 billion in 2024 to $1.89 billion in 2025, is expected to experience a compound annual…
Amniotic Products Market Size 2024 to 2031.
Market Overview and Report Coverage
Amniotic products refer to a type of medical product derived from the amniotic fluid or tissue of pregnant women. These products have various therapeutic applications in wound care, orthopedics, ophthalmology, and other medical fields.
The global Amniotic Products Market is expected to witness significant growth in the coming years, with a projected CAGR of 11.60% during the forecasted period. The increasing prevalence of chronic wounds,…
Global Amniotic Membrane Market Research Report 2023
Amniotic membrane is a sack that surrounds and protects the embryo, enclosing the amniotic cavity.
The global Amniotic Membrane market was valued at US$ 2910.7 million in 2022 and is anticipated to reach US$ 5213 million by 2029, witnessing a CAGR of 10.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global amniotic membrane market is supplemented owing to…
Global Amniotic Products Market is estimated to grow at a 8% CAGR to reach $1 bi …
Amniotic-derived products, including amniotic membrane and amniotic fluid products, are one subtype of orthobiologic which are considered a potential treatment option for augmentation of joint inflammation and healing. An amniotic membrane (AM) or amnion is a thin membrane forming a closed sac around the embryos or fetuses, and mammals and containing the amniotic fluid. The most common types of amniotic membranes used are cryopreserved amniotic membranes and lyophilized amniotic membranes.…
Amniotic Membrane Market | Cryopreserved Amniotic Membrane would continue to mai …
According to a new report published by Allied Market Research, titled, "Amniotic Membrane Market by Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030," The global amniotic membrane market size was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/4559
Amniotic membrane is the innermost layer…
Increased Demand for Ophthalmology Amniotic Membrane to Boost the Amniotic Membr …
250 Pages Amniotic Membrane Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
According to Fact MR's recent market research, sales of Amniotic Membrane to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.
Focus…
